Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma

Raymond K. Mulhern, Shawna L. Palmer, Thomas E. Merchant, Dana Wallace, Mehmet Kocak, Pim Brouwers, Kevin Krull, Murali Chintagumpala, Robyn Stargatt, David M. Ashley, Vida L. Tyc, Larry Kun, James Boyett, Amar Gajjar

Research output: Contribution to journalArticlepeer-review

330 Scopus citations

Fingerprint

Dive into the research topics of 'Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences